Caplin Point Laboratories Experiences Revision in Stock Evaluation Amid 52-Week High Achievement
Caplin Point Laboratories has recently been added to MarketsMojo's list following a revision in its score, reflecting its strong market performance. The stock has reached a new 52-week high, showcasing impressive growth and a significant outperformance compared to its sector, indicating a robust upward trend in its valuation.
Caplin Point Laboratories, a key player in the pharmaceuticals sector, achieved a notable milestone by hitting a new 52-week high of Rs. 2509.25 on December 17, 2024. This performance highlights the stock's resilience, as it outperformed its sector by a considerable margin on the same day. The stock's intraday high reflects a solid increase, further emphasizing its strong market presence.
Currently, Caplin Point Laboratories is trading above its various moving averages, indicating a sustained upward trajectory. Over the past year, the company has demonstrated remarkable growth, significantly outpacing the Sensex, which underscores its solid position within the midcap segment of the pharmaceuticals industry.
Caplin Point Laboratories has recently experienced a noteworthy adjustment in its evaluation, reflecting the company's strong performance and market position. The stock has reached a new 52-week high of Rs. 2509.25, marking a significant milestone for the pharmaceuticals and drugs sector player. On December 17, 2024, Caplin Point Laboratories outperformed its sector by 3.84%, with an intraday high showcasing a 3.9% increase. This upward momentum is further supported by the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust trend in its performance.
Over the past year, Caplin Point Laboratories has demonstrated impressive growth, achieving an increase of 98.27%. This remarkable performance stands in stark contrast to the Sensex, which recorded a growth of only 14.02%. Such results highlight the company's solid standing within the midcap segment of the pharmaceuticals industry.
In light of these developments, Caplin Point Laboratories has been added to MarketsMOJO's list, reflecting the positive sentiment surrounding its stock. Investors and analysts alike will be keenly observing the company's trajectory as it continues to navigate the competitive landscape of the pharmaceuticals sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
